As of 3:59pm ET
| +0.05 / +0.91%|
The 3 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 6.75, with a high estimate of 16.50 and a low estimate of 6.70. The median estimate represents a +21.62% increase from the last price of 5.55.
The current consensus among 3 polled investment analysts is to Hold stock in Juniper Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.